¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Tissue Antigens"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® tissue biopsy ÇÑ±Û Á¶Á÷»ý°Ë
¼³¸í   
  È¯ÀÚÀÇ º´ÀûÀΠÁ¶Á÷ÀÇ ÀϺθ¦ ¶¼¾î ³»¼­ º´¸®Á¶Á÷Ç¥º»À» ¸¸µé¾î¼­ Çö¹Ì°æÀûÀ¸·Î °Ë»çÇϴ °Í. ¿Ü°úÀû ¼ö¼úÀç·á·ÎºÎÅÍ º´¸®Á¶Á÷ÇÐÀû °Ë»ç¸¦ ÇÏ¿© »ýü³»ÀÇ º´º¯À» Ãß±¸Çϴ ºÐ¾ß¸¦ ¿Ü°úº´¸®ÇÐÀ̶ó°í ÇÑ´Ù. »ý°Ë¿¡´Â ½û±â»ý°Ë, ÃµÀÚħ»ý°Ë, ²ç¶Õ±â½Ä»ý°Ë, ³»½Ã°æ»ý°Ë ¿Ü¿¡ ¼¼Æ÷ÁøÀ̶ó°í ºÒ¸®¿ì´Â ¹Ú¸®¼¼Æ÷ÁøÀ̳ª ¼¼Ã´¼¼Æ÷Áø µî ¶³¾îÁø ¼¼Æ÷¸¦ µµ¸»°Ë»çÇϴ ¹æ¹ýÀÌ Æ÷ÇԵȴÙ.
¿µ¹® target tissue ÇÑ±Û Ç¥ÀûÁ¶Á÷
¼³¸í   
  È£¸£¸ó¿¡ ´ëÇÏ¿© Ç¥ÀûÀÌ µÇ´Â ¼¼Æ÷¶ó´Â Àǹ̷μ­ ±× È£¸£¸ó¿¡ ´ëÇÑ ¼ö¿ëü¸¦ °¡Áö°í Àִ ¼¼Æ÷. ¿¹¸¦ µé¾î Àν¶¸°Àº Àν¶¸° ¼ö¿ëü¸¦ °¡Áø ¼¼Æ÷¸¦ Ç¥Àû¼¼Æ÷·Î ÇÏ¿© ÀÌ ¼¼Æ÷¿¡¸¸ ÀÛ¿ëÇÑ´Ù.
¿µ¹® subcutaneous tissue, subcutis ÇÑ±Û ÇÇÇÏÁ¶Á÷
¼³¸í   
  ÇǺο¡¼­ ÁøÇÇÀÇ ¾Æ·§ºÎºÐÀ» ¸»ÇÔ. ¿©±â¿¡´Â Áö¹æÁ¶Á÷ÀÌ ¸¹´Ù. ±â´ÉÀº ¿­ÀÇ °Ý¸®, Ãæ°ÝÈí¼ö, ¿µ¾çÀúÀå¼Ò µîÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • lymphatic tissue
    ¸²ÇÁÁ¶Á÷
  • microvascular composite tissue transplantation
    ¹Ì¼¼Ç÷°üº¹ÇÕÁ¶Á÷À̽Ä
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • mucosa-associated lymphoid tissue
    Á¡¸·¿¬°ü¸²ÇÁÁ¶Á÷
  • muscular tissue
    ±Ù(À°)Á¶Á÷
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷
  • nervous tissue
    ½Å°æÁ¶Á÷
  • osseous tissue
    »ÀÁ¶Á÷, °ñÁ¶Á÷
  • osteogenic tissue
    »ÀÇü¼ºÁ¶Á÷, °ñÇü¼ºÁ¶Á÷
  • osteoid tissue
    Dz»ÀÁ¶Á÷, À¯°ñÁ¶Á÷
  • reticular tissue
    ±×¹°Á¶Á÷, ¸Á»óÁ¶Á÷
  • soft tissue
    ¹°··Á¶Á÷, ¿¬Á¶Á÷
  • soft tissue coverage
    ¿¬Á¶Á÷µ¤±â
  • scar tissue
    ÈäÅÍÁ¶Á÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • retained placental tissue
    ÀÜ·ùŹÝÁ¶Á÷
  • reticular tissue
    ±×¹°Á¶Á÷, ¼¼¸ÁÁ¶Á÷
  • scar tissue
    ÈäÅÍÁ¶Á÷
  • soft tissue
    ¿¬Á¶Á÷, ¹°··Á¶Á÷
  • subcutaneous tissue
    ÇǺιØÁ¶Á÷, ÇÇÇÏÁ¶Á÷
  • tissue typing
    Á¶Á÷Çü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´, ½Â¸ðÆÇ¸·º´
  • tissue damage
    Á¶Á÷¼Õ»ó
  • tissue degeneration
    Á¶Á÷º¯¼º
  • tissue dose
    Á¶Á÷¼±·®
  • elastic tissue
    ź·ÂÁ¶Á÷
  • epithelial tissue
    »óÇÇÁ¶Á÷
  • erectile tissue
    ¹ß±âÁ¶Á÷
  • tissue expander
    Á¶Á÷È®Àå±â
  • tissue expansion
    Á¶Á÷È®Àå(¼ú)
  • tissue factor
    Á¶Á÷ÀÎÀÚ
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷, Á¶Ç÷Á¶Á÷
  • tissue hypoxia
    Á¶Á÷Àú»ê¼ÒÁõ
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • angioblastic tissue
    Ç÷°ü¹ß»ýÁ¶Á÷
  • free water in stationary tissue
    Á¤Àû Á¶Á÷³» ÀÚÀ¯ ¼öºÐ
  • general connective tissue
    ÀϹݰáÇÕÁ¶Á÷.
  • gingival tissue esthetics
    Ä¡ÀºÁ¶Á÷½É¹Ì¼º.
  • granulation tissue
    À°¾ÆÁ¶Á÷(¡­ðÚòÄ)
  • gut-associated lymphatic tissue (GALT)
    Àå-¿¬°ü ¸²ÇÁÁ¶Á÷
  • hemopoietic tissue
    Ç÷__ü¼ºÁ¶Á__ Á¶Ç÷Á¶Á÷.
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷, Á¶Ç÷Á¶Á÷.
  • hemopoietic tissue
    Ç÷¾×Çü¼ºÁ¶Á÷
  • immunity, tissue
    Á¶Á÷¸é¿ª
  • pigment connective tissue
    »ö¼Ò°áÇÕÁ¶Á÷
  • pigment tissue
    »ö¼ÒÁ¶Á÷(ßäáÈðÚòÄ).
  • placental tissue
    ŹÝÁ¶Á÷.
  • prechondral tissue
    Dz¿¬°ñÁ¶Á÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bone-soft tissue interface
    °ñ¿¬ºÎÁ¶Á÷°æ°è¸é, °ñ¿¬ºÎÁ¶Á÷°øÀ¯¸é
  • bony tissue
    °ñ¼ºÁ¶Á÷.
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷(¡­ò·Û¸ðÚòÄ).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
  • cardiac muscular tissue
    ½ÉÀå±ÙÀ°Á¶Á÷
  • cartilage tissue
    ¿¬°ñÁ¶Á÷ ¹°··»ÀÁ¶Á÷
  • cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • chromaffin tissue
    Å©·ÒģȭÁ¶Á÷(¡­ðÚòÄ).
  • collagenous connective tissue
    ¾Æ±³°áÇÕÁ¶Á÷
  • compact bone tissue
    Ä¡¹Ð»ÀÁ¶Á÷
  • compact tissue
    Ä¡¹ÐÁ¶Á÷(¡­ðÚòÄ).
  • conducting tissue of heart
    ½ÉÀåÀüµµÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷(¡­ðÚòÄ).
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Conducting tissue of heart
    ½ÉÀåÀüµµÁ¶Á÷
    [¿¾ ¿ë¾î] ½ÉÀåÀüµµ°è
  • Collagenous connective tissue
    ¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ±³¿ø°áÇÕÁ¶Á÷
  • Cartilage tissue
    ¿¬°ñÁ¶Á÷ [¹°··»ÀÁ¶Á÷]
    [¿¾ ¿ë¾î] ¿¬°ñÁ¶Á÷
  • Submucosal tissue
    Á¡¸·¹ØÁ¶Á÷
    [¿¾ ¿ë¾î] Á¡¸·ÇÏÁ¶Á÷
  • Abnormality of tissue
    Á¶Á÷ÀÌ»ó
    [¿¾ ¿ë¾î] Á¶Á÷ÀÌ»ó
  • Notochordal tissue (Chordoma)
    ô»èÁ¶Á÷ (ô»èÁ¾)
    [¿¾ ¿ë¾î] ô»èÁ¶Á÷
  • Lamellar bone tissue
    ÃþÆÇ»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] ÃþÆÇ¼º°ñÁ¶Á÷
  • Compact bone tissue
    Ä¡¹Ð»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] Ä¡¹Ð°ñÁ¶Á÷
  • Dense collagenous connective tissue
    Ä¡¹Ð¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Ä¡¹Ð°áÇÕÁ¶Á÷
  • Renal tissue (Nephroblastoma)
    ÄáÆÏÁ¶Á÷ (ÄáÆÏ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½ÅÁ¶Á÷
  • Elastic connective tissue
    ź·Â°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ź·Â°áÇÕÁ¶Á÷
  • Prechondral tissue
    Dz¿¬°ñÁ¶Á÷
    [¿¾ ¿ë¾î] Àü¿¬°ñÁ¶Á÷
  • Subcutaneous tissue
    ÇǺιØÁ¶Á÷
    [¿¾ ¿ë¾î] ÇÇÇÏÁ¶Á÷
  • Angioblastic tissue
    Ç÷°ü¹ß»ýÁ¶Á÷
    [¿¾ ¿ë¾î] Ç÷°ü¸ðÁ¶Á÷
  • Connective tissue fibers
    °áÇÕÁ¶Á÷¼¶À¯
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¶À¯
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • tissue plasminogen activator
    Á¶Á÷(ðÚòÄ)Çö󽺹̳ëÀü Ȱ¼ºÀÚ (üÀàõí­)
  • tissue polypeptide antigen
    Á¶Á÷(ðÚòÄ)Æú¸®ÆéŸÀ̵å Ç׿ø (ù÷ê«)
  • tissue slice
    Á¶Á÷ õ¿± (ðÚòÄô¼ç¨)
  • tissue-specific enzyme
    Á¶Á÷ ƯÀÌ È¿¼Ò (ðÚòÄ÷åì¶ý£áÈ)
  • tissue thromboplastin
    Á¶Á÷(ðÚòÄ)Æ®·Òº¸ÇÃ¶ó½ºÆ¾
  • white adipose tissue
    ÈØ Áö¹æÁ¶Á÷ (ò·Û¸ðÚòÄ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proper connective tissue
    °íÀ¯°áÇÕÁ¶Á÷
  • pseudogating in flowing tissue
    À¯µ¿Á¶Á÷¿¡¼­ À§°ÔÀÌÆÃ
  • reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
  • reticular tissue
    ¼¼¸ÁÁ¶Á÷
  • retropharyngeal soft tissue space
    ÀεÎÈĺο¬ºÎÁ¶Á÷
  • scar tissue
    ¹ÝÈçÁ¶Á÷
  • soft tissue
    ¿¬Á¶Á÷
  • soft tissue calcification
    ¿¬Á¶Á÷¼®È¸È­
  • soft tissue technique
    ¿¬Á¶Á÷±â¹ý
  • stationary tissue
    Á¤Á¶Á÷
  • surrounding tissue
    ÁÖÀ§Á¶Á÷
  • tissue
    Á¶Á÷
  • tissue anoxia
    Á¶Á÷¹«»ê¼ÒÁõ
  • tissue characterization
    Á¶Á÷Ư¼º°¨º°
  • tissue contrast
    Á¶Á÷´ëÁ¶µµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
TCID tissue culture infective dose; tissue culture inoculated dose
TCID50 median tissue culture infective dose; 50% tissue culture infective dose
BTSS Biopsy Tissue Scrub Smear
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MAIPA Monoclonal Antibody-specific Immobilisation of Platelet Antigens
AT Adipose tissue
ATBF Adipose tissue blood flow
ATLPL Adipose tissue lipoprotein lipase
BALT Bronchus-associated Lymphoid tissue
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • connective tissue disease
    °áÇÕÁ¶Á÷ º´, °áÇÕÁ¶Á÷ Áúȯ
  • connective tissue fiber
    °áÇÕ Á¶Á÷ ¼¶À¯
  • connective tissue sheath of Key and Retzius
    Ű-·¹Ä¡¿ì½ºÀÇ °áÇÕ Á¶Á÷ ÃÊ
    ½Å°æ³»¸·, ƯÈ÷ ½Å°æ¼¶À¯ Á¾¸»Áö ÁÖÀ§ÀÇ ¾ãÀº ¿¬Àå.
  • degree of tissue pathology
    Á¶Á÷³» º´¼Ò Á¤µµ
  • dense connective tissue
    Ä¡¹Ð °áÇÕÁ¶Á÷
    ±³¿ø¼¶À¯°¡ dzºÎÇÏ°Ô °¡µæ Â÷ ÀÖ´Â °áÇÕÁ¶Á÷.
  • dense fibrous connective tissue
    Ä¡¹Ð ¼¶À¯¼º °áÇÕ Á¶Á÷
  • dentinal tissue
    »ó¾ÆÁú Á¶Á÷
    »ó¾ÆÁúÀ» ±¸¼ºÇϰí ÀÖ´Â Á¶Á÷.
  • elastic tissue
    ź·Â Á¶Á÷, ź¼º Á¶Á÷
    1. Ȳ»öÀÇ ¼¶À¯¼º Á¡¼º ´Ü¹éÁú
  • epithelial tissue
    »óÇÇ Á¶Á÷
    ¼¼Æ÷ »çÀÌ ¹°ÁúÀÌ °ÅÀÇ ¾ø¾î ÀÎÁ¢ ¼¼Æ÷¿Í ¹ÐÂøµÇ¾î ±¸¼ºÇϰí ÀÖÀ¸¸ç, Àå±âÀÇ Ç¥¸éÀ» µ¤°Å³ª ³»°­ÀÇ Ç¥¸éÀ» µ¤À¸¸ç ÀϺδ »ùÀ» ±¸¼ºÇÑ´Ù.
  • fibrous connective tissue
    ¼¶À¯¼º °áÇÕ Á¶Á÷
  • fibrous tissue
    ¼¶À¯ Á¶Á÷, ¼¶À¯¼º Á¶Á÷
  • flabby tissue
    À̵¿¼º Á¶Á÷
    »ó¾ÇÀ̳ª ÇϾǿ¡¼­ Áö³ªÄ¡°Ô Áõ½ÄµÇ¾î ¿òÁ÷ÀÌ´Â ¿¬Á¶Á÷.
  • flowing tissue
    À¯µ¿ Á¶Á÷, ±â·ù¼º Á¶Á÷
  • free water in stationary tissue
    Á¤Àû Á¶Á÷³» ÀÚÀ¯ ¼öºÐ
  • hard tissue
    °æÁ¶Á÷
    °ñ, ÃÊÀÚ ¿¬°ñ, ±×¸®°í ¼¶À¯ ¿¬°ñÀ» Æ÷ÇÔÇÏ´Â »ó´ëÀûÀ¸·Î ´Ü´ÜÇÑ °ñ°Ý Á¶Á÷.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
antigens, CD26 <enzyme, immunology> Cell-surface glycoproteins and serine protease, also known as dipeptidyl-peptidase IV, that play a role in t-lymphocyte activation. Cd26 binds to adenosine deaminase on the T-cell surface.
Registry number: EC 3.4.14.5
(12 Dec 1998)
antigens, CD27 <immunology> Dimeric membrane glycoproteins found on most T-lymphocytes. Activation of T-cells by the antigen receptor increases CD27 surface expression.
(12 Dec 1998)
antigens, CD28 <immunology> T-cell differentiation antigens that serve as the receptors for the b7 antigen (antigens, CD80) which modulates T-cell lymphokine production.
(12 Dec 1998)
antigens, CD29 <immunology> Integrin beta-1 chains which are expresssed as heterodimers noncovalently associated with specific alpha-chains of the CD49 family (CD49a-f). Cd29 is expressed on resting and activated leukocytes and is a marker for total very late activation antigens on cells. (barclay et al., the leukocyte antigen factsbook, 1993, p164)
(12 Dec 1998)
antigens, CD3 <immunology> A complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (receptors, antigen, T-cell). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (receptors, antigen, T-cell, gamma-delta).
(12 Dec 1998)
antigens, CD30 <immunology> Differentiation antigens normally present in a small number of cells in the lymph nodes and tonsils in vivo, but also capable of being induced in a wide range of cells in vitro. They are clinically useful as tumour markers for ki-1 lymphoma (lymphoma, large-cell, ki-1) and some cases of lymphomatoid papulosis, mycosis fungoides, and hodgkin's disease.
(12 Dec 1998)
antigens, CD31 <immunology> Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. Cd31 is highly expressed on endothelial cells and concentrated at the junctions between them.
(12 Dec 1998)
antigens, CD34 <immunology> Glycoproteins found on immature haematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.
(12 Dec 1998)
antigens, CD36 <immunology> Leukocyte differentiation antigens and major platelet membrane glycoproteins present on monocytes, endothelial cells, platelets, mammary epithelial cells, and a variety of cultured cell lines. They play major roles in adhesion phenomena, signal transduction, and haematopathology. Cd36 is also the receptor for thrombospondin and malaria-infected erythrocytes.
(12 Dec 1998)
antigens, CD4 <immunology> 55-kD glycoproteins originally defined as differentiation antigens on T-lymphocytes, but also found on other cells including monocytes/macrophages. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MHC (major histocompatibility complex) class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. Cd4 antigens also serve as HIV receptors, binding directly to the envelope protein gp120 on HIV.
The protein structure on the surface of a human cell that allows HIV to attach, enter, and thus infect a cell. CD4 receptors are present on CD4 cells (helper T-cells), macrophages and dendritic cells, among others. Normally, CD4 acts as an accessory molecule, forming part of larger structures (such as the T-cell receptor) through which Tcells and other cells signal each other.
(12 Dec 1998)
antigens, CD40 <immunology> Differentiation antigens found on all mature B-lymphocytes and some epithelial cells, carcinomas, and lymphoid dendritic cells. This is a member of the tumour necrosis factor superfamily. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centres.
(12 Dec 1998)
antigens, CD44 <immunology> Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. Cd44 antigens are the principle cell surface receptors for hyaluronate and this interaction mediates binding of lymphocytes to high endothelial venules.
(12 Dec 1998)
antigens, CD45 <immunology> High-molecular weight glycoproteins uniquely expressed on the surface of all leukocytes and their haemopoietic progenitors. The CD45 family consists of multiple members that are all products of a single gene. Cd45 expression is necessary for signalling through the T-cell receptor.
(12 Dec 1998)
antigens, CD5 <immunology> Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5.
(12 Dec 1998)
antigens, CD55 <immunology> Glycoproteins broadly distributed among haematopoietic and non-haematopoietic cells. Cd55 prevents the assembly of c3 convertase or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á